Evidence map›Paper›PMID 41415876›Full record

ArticleJournal of biological methods2025

The last imprint: Differential methylation assay for forensic identification of brain tissue and death determination.

Gal Bilinsky, Dan Grinstein, Anat Zvi, Adi Beth-Din, Ofir Israeli

Abstract read
In one paragraph

Article in Journal of biological methods, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gal BilinskyDepartment of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Central District 74100, Israel.
Dan GrinsteinScience & Technology Unit, Ministry of Defense, Hakirya, Tel Aviv 6473424, Israel.
Anat ZviDepartment of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Central District 74100, Israel.
Adi Beth-DinDepartment of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Central District 74100, Israel.
Ofir IsraeliDepartment of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Central District 74100, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The ability to test samples for the presence of specific tissues is useful for numerous forensic applications. More specifically, the identification of vital organ remains, such as the brain, in a crime scene or battlefield, can assist in determining the death of a missing person. In many cases, tissue samples are of insufficient quality or quantity for the application of histological methods, leaving forensic labs mostly restricted to immunological and catalytic assays designed to identify blood, semen, and saliva. Recent studies have suggested expression profiling-based methods for tissue and bodily fluid identification. Objective: We present a methylation-based assay for the detection of brain tissue in forensic samples. Methods: Genome-wide methylation data from 12 human tissues were analyzed to identify CpG sites uniquely methylated in brain tissue. Four candidate regions were selected based on high inter-tissue specificity and low intra-tissue variability. Targeted assays were developed using bisulfite conversion, polymerase chain reaction amplification, and next-generation sequencing, and validated based on reference tissues, mixtures, and environmentally degraded DNA samples. Results: Four regions displayed consistent brain-specific methylation with >94% single-read accuracy and complete sample-level discrimination at ≥5% brain DNA. The assay retained diagnostic performance in mixed and degraded samples, demonstrating robustness under typical forensic conditions. Conclusion: This study presents a sensitive and specific methylation-based assay for brain tissue identification. The approach enables reliable detection in degraded or composite materials and supports future integration of epigenetic biomarkers into forensic workflows for organ-source attribution.

Indexed as

Bisulfite sequencingBrainCrime sceneDNA methylationGenomicsHigh-throughput sequencing

Identifiers

PMID41415876
PMCPMC12709522

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.